Author Details

Vorsanger, PhD, MD, Gary, United States

  • Vol 10, No 3 (2014): May/June - Articles
    Evaluation of the tamper-resistant properties of tapentadol extended-release tablets: Results of in vitro laboratory analyses
    Abstract
  • Vol 11, No 3 (2015): May/June - Articles
    Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency
    Abstract
  • Vol 6, No 3 (2010): May/June - Articles
    Evaluation of study discontinuations with tapentadol immediate release and oxycodone immediate release in patients with low back or osteoarthritis pain
    Abstract